| 111. |
- Sousa-Uva, M, et al.
(author)
-
Reply to Evora and Albuquerque
- 2020
-
In: European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery. - : Oxford University Press (OUP). - 1873-734X. ; 57:1, s. 200-200
-
Journal article (other academic/artistic)
|
|
| 112. |
|
|
| 113. |
- Strüber, Martin, et al.
(author)
-
HeartMate II left ventricular assist device, early European experience
- 2008
-
In: European Journal of Cardio-Thoracic Surgery. - : Oxford University Press (OUP). - 1010-7940 .- 1873-734X. ; 34:2, s. 289-294
-
Journal article (peer-reviewed)abstract
- Objective: The novel axial flow left ventricular assist device HeartMate II was introduced into clinical practice in Europe as part of the pilot study and after CE approval in November 2005. In order to get an overview of the use and performance of the device in Europe a group of investigators was founded to compare the initial results. Methods: In a retrospective analysis of the first 101 consecutive cases in Europe, data were collected with regard to postoperative outcome and severe adverse events and anticoagulation protocols. Results were stratified by intention to treat as a bridge to transplant or as chronic support therapy in heart failure (destination therapy). Results: In 70% of patients, the HeartMate II was intended as a bridge to transplant therapy, in 30%, it was used as a destination therapy device. The perioperative mortality post implant was 20% in the bridge to transplant patients and 7% in the destination therapy arm. However, after 1 year a comparable survival was observed in both groups (69% destination therapy, 63% bridge to transplant). Main causes of death were multiple organ failure (n = 12) and cerebrovascular accidents (n = 5). All, but one cerebrovascular accident occurred in the first 9 days after surgery. Only one other death was reported thereafter and there was no mechanical failure of the device. Conclusions: Even in the early experience the HeartMate II was used as a chronic support device in a substantial number of patients in Europe. Although the total experience is still limited, the incidence of cerebrovascular accidents is very low and the survival beyond the perioperative period is excellent. © 2008 European Association for Cardio-Thoracic Surgery.
|
|
| 114. |
- Svedjeholm, Rolf, et al.
(author)
-
Are electrocardiographic Q-wave criteria reliable for diagnosis of perioperative myocardial infarction after coronary surgery?
- 1998
-
In: European Journal of Cardio-Thoracic Surgery. - 1010-7940 .- 1873-734X. ; 13:6, s. 655-661
-
Journal article (peer-reviewed)abstract
- Objective: A major assumption in cardiovascular medicine is that Q-waves on the electrocardiogram indicate major myocardial tissue damage. The appearance of a new Q-wave has therefore been considered the most reliable criterion for diagnosis of perioperative myocardial infarction (PMI) in cardiac surgery. In a study, originally intended to evaluate troponin-T as a marker of PMI, analysis of our data aroused the need to address the reliability of Q-wave criteria for diagnosis of PMI.Methods: In 302 consecutive patients undergoing coronary surgery, Q-wave and other electrocardiogram (ECG) criteria were compared with biochemical markers of myocardial injury and the postoperative course. All ECGs were analysed by a cardiologist blinded to the biochemical analyses and the clinical course.Results: The incidence of positive Q-wave criteria was 8.1%. Combined biochemical (CK-MB≥70 μg/l) and Q-wave criteria were found in 1.0%. Patients with new Q-waves did not have CK-MB or troponin-T levels significantly different from those without Q-waves. More than 25% of the Q-waves were associated with plasma troponin-T below the reference level (<0.2 μg/l) on the fourth postoperative day. Q-wave criteria alone did not influence the postoperative course. In contrast, biochemical markers correlated with clinical outcome.Conclusions: The majority of Q-waves appearing after coronary surgery were not associated with major myocardial tissue damage, and according to troponin-T one-fourth of the Q-waves were not associated with myocardial necrosis. Furthermore, the appearance of Q-waves had little influence on short term clinical outcome. Therefore, the use of Q-wave criteria as the gold standard for diagnosis of PMI may have to be questioned.
|
|
| 115. |
|
|
| 116. |
- Svedjeholm, Rolf, 1952-, et al.
(author)
-
Reply to H.S. Bedi and M.S. Kalkat
- 2000
-
In: European Journal of Cardio-Thoracic Surgery. - : Elsevier. - 1010-7940 .- 1873-734X. ; 17:2, s. 195-195
-
Journal article (other academic/artistic)abstract
- We would like to thank Dr Bedi and Dr Kalkat for drawing attention to another potential application of retrograde perfusion of the coronary sinus with oxygenated blood. The connection of the aortic and retrograde cannula to allow retrograde perfusion is beautiful in its simplicity. In contrast to our report on retrograde perfusion to treat severe myocardial ischemia during early stages of surgery, they seem to have employed retrograde perfusion in off pump surgery to avoid ischemia. However, in some cases they observed regression of ECG changes as retrograde perfusion was commenced. Although these type of clinical reports (like our own report) almost inevitably are anecdotal they do have a scientific basis (references given in the respective reports). According to current knowledge of coronary sinus anatomy and interventions, retrograde coronary sinus perfusion has the potential to alleviate myocardial ischemia caused by obstruction of antegrade flow to myocardium drained by the coronary sinus. This is in agreement with the reported experience by Drs Bedi and Kalkat, who found signs of ischemia only while performing anastomoses to the right coronary artery.Certainly, the method described deserves further evaluation in off pump surgery as it potentially allows unhurried anastomosis, and it could contribute to a reduced need for conversion to on-pump procedures and an increasing proportion of off-pump procedures in multi-vessel coronary disease. If the latter, on the other hand, is a desirable evolution for the majority of patients remains to be established.
|
|
| 117. |
|
|
| 118. |
|
|
| 119. |
|
|
| 120. |
|
|
